How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Gold Nanorod Market
- By Aspect Ratio: Low Aspect Ratio (2-3), Medium Aspect Ratio (4-6), High Aspect Ratio (7 and above)
- By Surface Functionalization: PEGylated Gold Nanorods, CTAB-coated Gold Nanorods, Silica-coated Gold Nanorods, Antibody-conjugated Gold Nanorods, Peptide-functionalized Gold Nanorods
- By Application: Biomedical Imaging, Photothermal Therapy, Drug Delivery, Sensing and Diagnostics, Catalysis
- By Synthesis Method: Seed-Mediated Growth, Template-Assisted Synthesis, Electrochemical Synthesis, Photochemical Synthesis
- By End-User Industry: Pharmaceutical and Biotechnology, Electronics and Optoelectronics, Chemical Industry, Academic and Research Institutions
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Low Aspect Ratio (2-3) leads By Aspect Ratio at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.179 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.187 →
Full report · locked preview
Everything inside the Gold Nanorod Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Aspect Ratio 3
Surface Functionalization 5
Application 5
Synthesis Method 4
End-User Industry 4
Companies profiled
Nanopartz Inc.
Cytodiagnostics Inc.
nanoComposix Inc.
Sigma-Aldrich (Merck Group)
Ted Pella Inc.
BBI Solutions
Ocean Nanotech LLC
Nanocs Inc.
Nanopartz
Nanophase Technologies Corporation
Strem Chemicals Inc.
Nanostructured & Amorphous Materials Inc.
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Nanopartz Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Cytodiagnostics Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →nanoComposix Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Sigma-Aldrich (Merck Group)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Ted Pella Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →BBI Solutions
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Ocean Nanotech LLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nanocs Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Nanopartz
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Nanophase Technologies Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Strem Chemicals Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Nanostructured & Amorphous Materials Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →NanoHybrids Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →NanoIntegris
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,013M by 2033 · 5.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Low Aspect Ratio (2-3)73.0
- Medium Aspect Ratio (4-6)17.2
- High Aspect Ratio (7 and above)9.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$877.8M → $1,189M · 3.9%
Europe$611.8M → $948.1M · 5.6%
Asia Pacific$558.6M → $788.5M · 4.4%
Latin America$345.8M → $529.5M · 5.5%
Middle East and Africa$266.0M → $390.0M · 4.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.232026
5.242027
5.252028
5.262029
5.272030
5.292031
5.292032
5.312033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Nanopartz Inc.17.5
- Cytodiagnostics Inc.23.9
- nanoComposix Inc.8.0
- Sigma-Aldrich (Merck Group)4.7
- Ted Pella Inc.8.2
- BBI Solutions9.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Aspect Ratio21.4%
Surface Functionalization12.3%
Application31.9%
Synthesis Method22.3%
End-User Industry12.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.9
- Europe24.7
- Asia Pacific20.5
- Latin America13.8
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Nanopartz Inc. | 76 | 86 | 94 | 89 | 96 | 81 | 87 |
| Cytodiagnostics Inc. | 81 | 91 | 89 | 75 | 70 | 87 | 82 |
| nanoComposix Inc. | 86 | 73 | 83 | 63 | 84 | 63 | 75 |
| Sigma-Aldrich (Merck Group) | 76 | 65 | 66 | 67 | 80 | 77 | 72 |
| Ted Pella Inc. | 63 | 54 | 64 | 51 | 58 | 57 | 58 |
| BBI Solutions | 70 | 59 | 62 | 59 | 70 | 53 | 62 |
| Ocean Nanotech LLC | 57 | 40 | 49 | 43 | 50 | 53 | 49 |
| Nanocs Inc. | 51 | 41 | 45 | 56 | 50 | 36 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Nanopartz Inc.
- Cytodiagnostics Inc.
- nanoComposix Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Nanopartz Inc. | ◐ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Cytodiagnostics Inc. | ◐ | ◐ | ✓ | ◐ | ◐ | ✓ |
| nanoComposix Inc. | ✓ | ◐ | ✓ | − | ✓ | − |
| Sigma-Aldrich (Merck Group) | ✓ | − | ◐ | − | ◐ | ◐ |
| Ted Pella Inc. | ◐ | − | ✓ | − | − | ◐ |
| BBI Solutions | ◐ | − | ◐ | − | ◐ | ◐ |
| Ocean Nanotech LLC | − | − | − | ◐ | ◐ | − |
| Nanocs Inc. | ◐ | − | ◐ | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Nanopartz Inc.87
2Cytodiagnostics Inc.82
3nanoComposix Inc.75
4Sigma-Aldrich (Merck Group)72
5BBI Solutions62
6Ted Pella Inc.58
7Ocean Nanotech LLC49
8Nanocs Inc.47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Nanopartz Inc.Cytodiagnostics Inc.
Challenger2
Strong scale, closing on the leaders.
nanoComposix Inc.Sigma-Aldrich (Merck Group)
Contender2
Focused players with pockets of strength.
Ted Pella Inc.BBI Solutions
Niche2
Specialists in a single segment or region.
Ocean Nanotech LLCNanocs Inc.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Aspect Ratio in North America, then scale across Gold Nanorod Market — a $76M beachhead inside a $1.34B market.
Beachhead (SOM)$76Mobtainable near-term
Serviceable (SAM)$528Mreachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Low Aspect Ratio (2-3)
Best fit — highest urgency & budget in Aspect Ratio.
Economic buyer76 fit
Medium Aspect Ratio (4-6)
Strong fit — clear ROI and a fast path to value.
End user67 fit
High Aspect Ratio (7 and above)
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Aspect Ratio in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Surface Functionalization & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales45%
Partner / channel27%
Digital / self-serve18%
Marketplaces10%
Positioning & messaging
§GTM 2 · p.194 →For Aspect Ratio leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Gold Nanorod Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified25%
Evaluation14%
Closed-won6%
$10.1KCAC
$59KLTV
5.8:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Gold Nanorod Market is a resilient opportunity — $643M by 2033, compounding at 4.3%.
TAM · 2025$459Mtoday
TAM · 2033$643Mforecast
CAGR4.3%2027–2033
Cumulative$4.92Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$643MTotal addressable market
SAM$246MServiceable available market
SOM$42MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.3% CAGR
Demand compounds through 2033, outpacing GDP across Aspect Ratio.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Aspect Ratio moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$643MLarge & growingTAM by 2033 at 4.3% CAGR
$246MServiceable nowreachable with today’s model
$42MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$501MBear2.8% CAGR
$643MBase4.3% CAGR
$823MBull5.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Surface Functionalization optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Gold Nanorod Market — a $2.69B market by 2033. Plan: grow share from 7.8% to 14.2%.
Market size · 2033$2.69Btotal addressable
Market CAGR7.4%2027–2033
Target share14.2%from 7.8% today
Revenue ambition$381Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.8% | 14.2% | On track |
| Revenue | $190M | $381M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 37.9% | 44.1% | Behind |
| Customer retention | 85.8% | 96.3% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Aspect Ratio
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Surface Functionalization capability
A defensible second engine — invest in Surface Functionalization to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Aspect Ratio share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Surface Functionalization
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $50M capacity & capability investment
- Greenlight bolt-on M&A in Surface Functionalization
- Authorise North America expansion plan
- Fund R&D program for Aspect Ratio leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Gold Nanorod Market conversation — a $10.8B market you can size, segment and defend in minutes.
Market size · 2033$10.8Btotal opportunity
Growth9.7%CAGR to 2033
Addressable buyers1,026+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Aspect Ratio
Goal Grow share in Aspect Ratio
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 4 mopayback period
$76K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Nanopartz Inc.Cytodiagnostics Inc.nanoComposix Inc.Sigma-Aldrich (Merck Group)Ted Pella Inc.BBI SolutionsOcean Nanotech LLCNanocs Inc.+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Gold Nanorod Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Gold Nanorod Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Immunoadsorbent Column Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportImmunization Syringe Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportImmunity Support Ingredients Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportImmunity Supplements Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportImmunity Sleep Supplements Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportImmunity Gummies Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportImmune System Allergy Treatment Market
Market size, share, segmentation and regional forecast.
$825M market · 2025 base year
View reportImmune Support Supplements Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportImmune Support Products Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportImmune Support Gummies Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportImmune Supplements Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportHandheld Imager Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.